Given the above‐mentioned crucial roles of RAB3B in regulating chordoma tumorigenicity and mTORC1/S6 signaling, we further explored the inhibitory effects of targeting mTORC1 signaling on chordoma via rapamycin and dactolisib. The gene discussed is RPS6; the disease is chordoma.